Trump’s proposed generic drug tariffs ‘not practical’, says Indian pharma; US consumers will pay the price

Trump said generic drugs would face zero tariffs for two years, followed by a 100% tariff in the third year and 200% thereafter, to encourage companies to set up manufacturing in the US